130 related articles for article (PubMed ID: 2945270)
21. [Treatment of hemophiliacs with inhibitors].
Fujimaki M
Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
[No Abstract] [Full Text] [Related]
22. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)].
Verroust F; Moussard C; Allain JP
Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962
[TBL] [Abstract][Full Text] [Related]
23. The use of epsilon-aminocaproic acid for the management of hemophilia in dental and oral surgery patients.
Evans BE
J Am Dent Assoc; 1977 Jan; 94(1):21. PubMed ID: 264310
[No Abstract] [Full Text] [Related]
24. The dental management of patients with spontaneous acquired factor VIII inhibitors.
Hasson DM; Poole AE; de la Fuente B; Hoyer LW
J Am Dent Assoc; 1986 Oct; 113(4):633-6. PubMed ID: 2945852
[TBL] [Abstract][Full Text] [Related]
25. [Inhibitor hemophilia in oral surgery].
Schulz S
Zahn Mund Kieferheilkd Zentralbl; 1984; 72(8):824-8. PubMed ID: 6240865
[No Abstract] [Full Text] [Related]
26. The therapeutic role of epsilon-aminocaproic acid (EACA) for dental extractions in hemophiliacs.
Walsh PN; Rizza CR; Evans BE; Aledort LM
Ann N Y Acad Sci; 1975 Jan; 240():267-76. PubMed ID: 1078619
[TBL] [Abstract][Full Text] [Related]
27. [Dental care for hemophilic patients. II. Consequences for dental practice].
Ned Tijdschr Tandheelkd; 1982 May; 89(5):200-5. PubMed ID: 6213874
[No Abstract] [Full Text] [Related]
28. Oral bleeding in hemophilia: treatment with epsilon aminocaproic acid and replacement therapy.
Corrigan JJ
J Pediatr; 1972 Jan; 80(1):124-8. PubMed ID: 4536942
[No Abstract] [Full Text] [Related]
29. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
[TBL] [Abstract][Full Text] [Related]
30. Use of activated prothrombin complex concentrate in a severely hemophilic patient with Factor VIII inhibitor.
Garehime WJ; Pecaro BC; Green D
J Oral Maxillofac Surg; 1983 Apr; 41(4):262-4. PubMed ID: 6220139
[No Abstract] [Full Text] [Related]
31. [Dental care for hemophilic patients. I. General discussion].
Ned Tijdschr Tandheelkd; 1982 Apr; 89(4):143-9. PubMed ID: 6213873
[No Abstract] [Full Text] [Related]
32. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
Mahasandana C; Patharathienskul D; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
[TBL] [Abstract][Full Text] [Related]
33. Hemophilia.
Green D
Postgrad Med; 1974 May; 55(5):129-33. PubMed ID: 4596315
[No Abstract] [Full Text] [Related]
34. A comparison between a serum fraction and FEIBA fraction in haemophilia.
Hutton RA; Dormandy K; Nour-Eldin F
New Istanbul Contrib Clin Sci; 1980; 13(1):9-22. PubMed ID: 6774316
[No Abstract] [Full Text] [Related]
35. Current concepts in the management of hemophilia.
Abildgaard CF
Semin Hematol; 1975 Jul; 12(3):223-32. PubMed ID: 1079631
[No Abstract] [Full Text] [Related]
36. New activated factors IX product in haemophilia.
Abonstam A; Aston L; Wassef M; Hamad Z
Lancet; 1980 Dec; 2(8207):1294. PubMed ID: 6108461
[No Abstract] [Full Text] [Related]
37. Failure of activated prothrombin complex concentrates in a hemophiliac with an anti-factor VIII antibody.
Blatt PM; White GC; McMillan CW; Webster WP
JAMA; 1984 Jan; 251(1):67. PubMed ID: 6418898
[No Abstract] [Full Text] [Related]
38. [The problem of factor VIII inhibitors in patients with congenital coagulopathies].
Klare M
Z Gesamte Inn Med; 1983 Jan; 38(2):47-50. PubMed ID: 6407220
[TBL] [Abstract][Full Text] [Related]
39. Epsilon-Aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial.
Walsh PN; Rizza CR; Matthews JM; Eipe J; Kernoff PB; Coles MD; Bloom AL; Kaufman BM; Beck P; Hanan CM; Biggs R
Br J Haematol; 1971 May; 20(5):463-75. PubMed ID: 4931484
[No Abstract] [Full Text] [Related]
40. Epsilon-aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro.
Ghosh K; Shetty S; Pathare A; Mohanty D
Acta Haematol; 2000; 103(2):67-72. PubMed ID: 10838448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
